Name | varenicline tartrate |
---|---|
Synonyms |
7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine tartrate Champix
(2R,3R)-3-carboxy-2,3-dihydroxypropanoate de (1R,12S)-5,8-diaza-14-azoniatétracyclo[10.3.1.0.0]hexadéca-2(11),3,5,7,9-pentaène Chantix (1R,12S)-5,8-Diaza-14-azoniatetracyclo[10.3.1.0.0]hexadeca-2(11),3,5,7,9-pentaene (2R,3R)-3-carboxy-2,3-dihydroxypropanoate (1R,12S)-5,8-Diaza-14-azoniatetracyclo[10.3.1.0.0]hexadeca-2(11),3,5,7,9-pentaen-(2R,3R)-3-carboxy-2,3-dihydroxypropanoat Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with (6R,10S)-7,8,9,10-tetrahydro-6,10-methano-6H-azepino[4,5-g]quinoxaline (1:1) Champix Varenicline tartrate |
Description | Varenicline Tartrate(CP 526555;Champix) is a nicotinic receptor partial agonist; it stimulates nicotine receptors more weakly than nicotine itself does.IC50 value:Target: α4β2 nAChRVarenicline(CP 526555; Champix; Chantix) is a prescription medication used to treat smoking addiction. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms Varenicline(CP 526555; Champix; Chantix) can assist some patients to quit smoking. |
---|---|
Related Catalog | |
References |
[5]. Varenicline |
Boiling Point | 400.6ºC at 760 mmHg |
---|---|
Melting Point | 206-208ºC |
Molecular Formula | C17H19N3O6 |
Molecular Weight | 361.35 |
PSA | 23.79000 |
LogP | 4.49528 |
Storage condition | Desiccate at RT |
Water Solubility | DMSO: >5mg/mL |
Symbol |
GHS02, GHS06, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H225-H301 + H311 + H331-H370 |
Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
Hazard Codes | Xn,N,T,F |
Risk Phrases | 22-50-39/23/24/25-23/24/25-11 |
Safety Phrases | 22-57-45-36/37-16-7 |
RIDADR | UN 3077 9 / PGIII |
Flash Point(F) | 48.2 °F |
Flash Point(C) | 9 °C |
~64% 375815-87-5 |
Literature: Medichem, S.A. Patent: US2012/4239 A1, 2012 ; Location in patent: Page/Page column 12 ; |
Precursor 2 | |
---|---|
DownStream 0 |